The wide variability in the expression levels of miR-29a, miR-222 and miR-132 suggests that they may serve as useful predictive biomarkers for evaluating diabetes risk in hyperglycemic pregnant women. Further studies involving longitudinal follow-up of hyperglycaemic pregnant women are needed to determine the predictive value of these microRNAs.
Lachashvili et al. (Mon,) studied this question.